Delmar Chemicals is an API manufacturer based in Canada. It holds 30 active US drug master files across a filed portfolio of 15 molecules. Its GMP standing is certified by US FDA. Its most recent recorded inspection, by US FDA, closed on 18 September 2025 as NAI.
NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.
| Site | FDA FEI |
|---|---|
| Canada, Canada | 3002806795 |
| Molecule | Regulators | Docs |
|---|---|---|
| Apixaban | US FDA | 2 |
| Eslicarbazepine Acetate | US FDA | 2 |
| Esmolol | US FDA | 2 |
| Fluorescein | US FDA | 2 |
| Lapatinib | US FDA | 2 |
| Methazolamide | US FDA | 2 |
| Mirabegron | US FDA | 2 |
| Montelukast | US FDA | 2 |
| Pentamidine | US FDA | 2 |
| Pyrazinamide | US FDA | 2 |
| Rosuvastatin | US FDA | 2 |
| Solifenacin Succinate | US FDA | 2 |
| Sorafenib | US FDA | 2 |
| Succinylcholine | US FDA | 2 |
| Tofacitinib | US FDA | 2 |
Also appears on these molecule pages
| Regulator | Filings | GMP certificates |
|---|---|---|
| MINSA (CR) | 1 | None |
| US FDA | None | 1 |
Choose your molecules and target markets. Delmar Chemicals comes back tiered against every other supplier able to file there.
Start for free